KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Invested Capital: 2012-2025

Historic Return on Invested Capital for Vertex Pharmaceuticals (VRTX) over the last 5 years, with Sep 2025 value amounting to 0.19%.

  • Vertex Pharmaceuticals' Return on Invested Capital was N/A to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year change of. This contributed to the annual value of 0.20% for FY2023, which is 7.00% down from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Return on Invested Capital stood at 0.19%, which was down 1.31% from 0.19% recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Invested Capital peaked at 0.29% during Q2 2022, and registered a low of 0.18% during Q4 2023.
  • For the 3-year period, Vertex Pharmaceuticals' Return on Invested Capital averaged around 0.20%, with its median value being 0.19% (2025).
  • In the last 5 years, Vertex Pharmaceuticals' Return on Invested Capital dropped by 9bps in 2021 and then rose by 8bps in 2022.
  • Quarterly analysis of 5 years shows Vertex Pharmaceuticals' Return on Invested Capital stood at 0.24% in 2021, then climbed by 1bps to 0.25% in 2022, then declined by 6bps to 0.18% in 2023, then decreased by 3bps to 0.19% in 2024, then reached 0.19% in 2025.
  • Its Return on Invested Capital was 0.19% in Q3 2025, compared to 0.19% in Q2 2025 and 0.19% in Q1 2024.